HealthSTAT News
STAT+: Lilly wins approval for once-weekly insulin shot
The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.
Join the argument
House rules →Comments load as you scroll.